FILTER

LATEST INTERVIEWS

Jeff Butler

PRESIDENT, AMPAC FINE CHEMICALS, AN SK PHARMTECO COMPANY
"Outside of our manufacturing capabilities, AFC is investing and featuring AMPAC Analytical given the growing demand for pharmaceutical testing services."

Marcelo Awad

EXECUTIVE DIRECTOR, WEALTH MINERALS
"Just by developing known reserves, even without exploration success, Chile can increase its copper production by around 2 million t/y and its lithium production by around 1 million t/y."

Antonio Samaniego

DIRECTOR, SRK CONSULTING - PERÚ
SRK Consulting analyzes the current state of the Peruvian mining industry. (Spanish interview)

Louis Kassa

PRESIDENT & CEO, PENNSYLVANIA BIOTECHNOLOGY CENTER (PABC)
"Our blueprint to success has manifested in six IPOs and over US$3 billion worth of company value created."

Jan Kengelbach

CEO, AENOVA GROUP
"While it's always easier to deny a certain service if you don't yet have the technical expertise in a particular area, in the long-term it is advantageous to explore the possibility of investing in that area with the customer."

Nolan Peterson

CEO, WORLD COPPER LTD.
"We have recently transitioned from exploration to early stage development and have an exciting runway ahead of us."

José Pablo Domínguez

GENERAL MANAGER – SOUTH AMERICA, ME ELECMETAL
"ME Elecmetal is working on several initiatives with mining companies to make changes to processes and products, such as upgrades to mill liners that allow mining operations to run more safely and efficiently."

John Hong

APAC SALES DIRECTOR AND SINGAPORE COUNTRY HEAD, INFINEUM
"A combination of unprecedented shipping costs coupled with steeply rising raw material costs and challenges around securing raw materials has had the entire additives industry struggling to pass on their costs."

Alexander Donau

APAC REGIONAL HEAD, LESCHACO
"Though a major change in the design and organization of global supply chains does not happen overnight, we do see a lot more caution in the medium-to-long-term planning."

Russell Trenary

PRESIDENT & CEO, OUTLOOK THERAPEUTICS
"If our ophthalmic bevacizumab is approved, we will potentially enhance the standard of care for patients with disorders like wet AMD, diabetic macular edema, and branch retinal vein occlusion by removing concerns related to off-label repackaged IV product."

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

Africa Energy 2024 - Pre-release

The pre-release edition of Africa Energy 2024 comprises analysis based on over 80 interviews with ministers and leading executives from IOCs, NOCs, independents, associations, investors and service providers, to provide an in-depth and holistic view of sub-Saharan Africa’s ever-evolving energy sector.

PARTNER EVENTS